Skip to content
OpenCapital
Get started

Acadia Pharmaceuticals ACAD Enterprise value

Enterprise value at other companies

Biogen logo
BiogenBIIB
$30.08B+34.9%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.41B+18.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.27B-4.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.2B+77.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$16.77B+178%
TG Therapeutics logo
TG TherapeuticsTGTX
$5.62B-11.1%

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M—
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.7B+37.0%
P/E9.9×-2.0×
P/S3.4×+0.7×

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%—

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0×0.0×
Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

$3.8Bmarket cap+$50.8Mtotal debt−$282.2Mcash and equivalents=$3.56B

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's enterprise value?
Acadia Pharmaceuticals (ACAD) reported enterprise value of $3.56B in Q1 2026.
How has Acadia Pharmaceuticals's enterprise value changed year-over-year?
Acadia Pharmaceuticals's enterprise value increased by 36.6% year-over-year, from $2.61B to $3.56B.
What is the long-term trend for Acadia Pharmaceuticals's enterprise value?
Over 5 years (2020 to 2025), Acadia Pharmaceuticals's enterprise value has grown at a -12.0% compound annual growth rate (CAGR), from $8.32B to $4.39B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.